Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | BH57H | — |
administered a dose of Kinrix to a patient who is 3 years old/ HCP was not sure if it was Kinrix or a dose of Infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number BH57H, expiry date 07-JUL-2026) for prophylaxis. Concomitant products included DIPHTHERIA VACCINE TOXOID;PERTUSSIS VACCINE ACELLULAR 3-COMPONENT;TETANUS VACCINE TOXOID (INFANRIX). On 08-APR-2025, the patient received Kinrix. On 08-APR-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administered a dose of Kinrix to a patient who is 3 years old/ HCP was not sure if it was Kinrix or a dose of Infanrix). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-AUG-2025 A registered nurse called to report that they administered a dose of Kinrix to a patient who was 3 years old, which led to an inappropriate age at vaccine administration. Patient did not experience any adverse event. HCP (health care professional) was not sure if it was Kinrix or a dose of Infanrix the vaccine that was administered to the patient. The reporter wanted to know was this a valid dose.
INFANRIX